 SAN DIEGO, March 9, 2022 PRNewswire -- Viracta Therapeutics, Inc. Nasdaq: VIRX, a precision oncology company targeting virus-associated malignancies, today announced that company leadership is scheduled to participate in a fireside chat at the 32nd Annual Oppenheimer Healthcare Conference, on Wednesday, March 16, 2022, at 10:40 a.m. ET. A webcast of the fireside chat will be available on the Investors section of the Viracta website under Events and Webcasts at 